Advances in medical genetics have redefined diagnostics practices all over the world. Genetic testing has made it feasible not only to diagnose and treat rare genetic syndromes but also determine risk for common diseases and optimize their prevention.
With this vision, PanGenomics, a molecular and genetic laboratory was founded in 2014. An N.A.B.L. accredited PanGenomics, a subsidiary of Sterling Accuris Diagnostics offers the opportunity to improve health outcomes with genetic testing and counseling.
Moreover, PanGenomics* has also been authorised by ICMR & Govt. of India to conduct COVID-19/ Corona Testing by RT –PCR Method.
PanGenomics facilitates the most up-to-date genetic testing options with extensive support from trained and certified medical geneticists and genetic counselors. With indepth genetic counselling, PanGenomics to take patient care to the next level in coordination with referring physicians, to meet the needs of the patients and their families.
This division is headed by Dr. Shashi P. Singh, who has more than 12 years of multidimensional experience in Molecular Diagnostics & R&D, aimed at improving quality and providing affordable molecular and genetic tests.
*(Reg. no. PGIA001)
Mission : To bring genetic information into mainstream medical practice to improve the quality of healthcare for everyone
Genetic Testing: We offer clinical genetic testing for over 300 different genetic conditions using various technologies including Karyotyping, Fluorescence in situ hybridization (FISH), Array Comparative Genomic Hybridization (aCGH), PCR, real time PCR, Multiplex Ligation-dependent Probe Amplification (MLPA), repeat expansion analysis, Sanger sequencing and Next Generation Sequencing (NGS).
Genetic Testing Menu
Counselling: PanGenomics offers technical consultation regarding testing and its interpretation to medical professionals. The process helps the medical professional to clearly understand the genetic test results, diagnosis and the options for treatment. Counselling the patients can help assess risks and determine the most appropriate genetic testing options.
Contract Research Organizations (CRO): PanGenomics acts as a companion and helps Contract Research Organizations (CRO)s to co-relate and determine the impact of genetics on the outcome of the trials. At times, it collaborates with CROs to develop a companion diagnostic.
Advanced Genetics Solutions: PanGenomics has developed a range of products to assess the risk of developing disease, facilitate diagnosis, predict disease progression and patients counselling.